Pancreatic Disorders & Therapy

Pancreatic Disorders & Therapy
Open Access

ISSN: 2165-7092

+44-1477412632

Citations Report

Citations Report - Pancreatic Disorders & Therapy [129 Articles]

The articles published in Pancreatic Disorders & Therapy have been cited 129 times by eminent researchers all around the world. Following is the list of articles that have cited the articles published in Pancreatic Disorders & Therapy.

Boselli C, Barberini F, Listorti C, Castellani E, Renzi C, et al. (2015) Distal pancreatectomy with splenic preservation: A short-term outcome analysis of the Warshaw technique. International Journal of Surgery 21: S40-S43.

Elabbasy F, Gadde R, Hanna MM, Sleeman D, Livingstone A, etal. (2015) Minimally invasive spleen-preserving distal pancreatectomy: Does splenic vessel preservation have better postoperative outcomes? A systematic review and meta-analysis. Hepatobiliary & Pancreatic Diseases International 14: 346-353.

Partelli S, Cirocchi R, Randolph J, Parisi A, Coratti A, etal. (2016) A systematic review and meta-analysis of spleen-preserving distal pancreatectomy with preservation or ligation of the splenic artery and vein. The Surgeon 14: 109-118.

RCK Rajendran S, ECC Ejike C, Gong M, Hannah W, C Udenigwe C (2017) Preclinical Evidence on the Anticancer Properties of Food Peptides. Protein and Peptide Letters 24: 126-136.

Wu X, Wu G, Wu Z, Yao X, Li G (2015) MiR-200a Suppresses the Proliferation and Metastasis in Pancreatic Ductal Adenocarcinoma through Downregulation of DEK Gene. Translational oncology 9: 25-31.

Romney E, Nagaraj VJ (2015) In Vitro Model Systems to Investigate Drug Resistance Mechanisms in Pancreatic Cancer Cells. Advances in Biological Chemistry 5: 286.

Grant TJ, Hua K, Singh A (2016) Chapter Six-Molecular Pathogenesis of Pancreatic Cancer. Progress in Molecular Biology and Translational Science 144: 241-275.

Ma J, Zeng F, Ma C, Pang H, Fang B, et al. (2016) Synergistic reversal effect of epithelial-to-mesenchymal transition by miR-223 inhibitor and genistein in gemcitabine-resistant pancreatic cancer cells. American Journal of Cancer Research 6: 1384.

Li Z, Guo J, Xie K, Zheng S (2015) Vitamin D receptor signaling and pancreatic cancer Cell EMT. Current pharmaceutical design 21: 1262-1267.

Sureban SM, Qu D, Houchen CW (2015) Regulation of miRNAs by agents targeting the tumor stem cell markers DCLK1, MSI1, LGR5, and BMI1. Current pharmacology reports 1: 217-222.

Schiavone M, Rampazzo E, Casari A, Battilana G, Persano L, et al. (2014) Zebrafish reporter lines reveal in vivo signaling pathway activities involved in pancreatic cancer. Disease models & mechanisms 7: 883-894.

Qu D, Johnson J, Chandrakesan P, Weygant N, May R, Aiello N, et al. (2017) Doublecortin-like kinase 1 is elevated serologically in pancreatic ductal adenocarcinoma and widely expressed on circulating tumor cells. PloS one 10: e0118933.

RCK Rajendran S, ECC Ejike C, Gong M, Hannah W, C Udenigwe C (2017) Preclinical Evidence on the Anticancer Properties of Food Peptides. Protein and Peptide Letters 24: 126-136.

Wu X, Wu G, Wu Z, Yao X, Li G (2016) MiR-200a Suppresses the Proliferation and Metastasis in Pancreatic Ductal Adenocarcinoma through Downregulation of DEK Gene. Translational oncology 9: 25-31.

Romney E, Nagaraj VJ (2015) In Vitro Model Systems to Investigate Drug Resistance Mechanisms in Pancreatic Cancer Cells. Advances in Biological Chemistry 5: 286.

Grant TJ, Hua K, Singh A (2016) Chapter Six-Molecular Pathogenesis of Pancreatic Cancer. Progress in Molecular Biology and Translational Science 144: 241-275.

Ma J, Zeng F, Ma C, Pang H, Fang B, et al. (2016) Synergistic reversal effect of epithelial-to-mesenchymal transition by miR-223 inhibitor and genistein in gemcitabine-resistant pancreatic cancer cells. American Journal of Cancer Research 6: 1384.

Li Z, Guo J, Xie K, Zheng S (2015) Vitamin D receptor signaling and pancreatic cancer Cell EMT. Current pharmaceutical design 21: 1262-1267.

Sureban SM, Qu D, Houchen CW (2015) Regulation of miRNAs by agents targeting the tumor stem cell markers DCLK1, MSI1, LGR5, and BMI1. Current pharmacology reports 1: 217-222.

Schiavone M, Rampazzo E, Casari A, Battilana G, Persano L,  et al. (2014) Zebrafish reporter lines reveal in vivo signaling pathway activities involved in pancreatic cancer. Disease models & mechanisms 7: 883-894.

Top